Page last updated: 2024-08-24

irinotecan and Uremia

irinotecan has been researched along with Uremia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukubo, T; Hojyo, A; Izumi, S; Kambara, K; Katsube, Y; Koide, H; Minegaki, T; Nishiguchi, K; Ochiai, M; Ogawa, K; Shima, D; Torii, N; Tsujimoto, M; Yamakawa, T1
Furukubo, T; Hojo, A; Izumi, S; Katsube, Y; Koide, H; Minegaki, T; Nishiguchi, K; Ochiai, M; Shima, D; Tsujimoto, M; Yamakawa, T1

Other Studies

2 other study(ies) available for irinotecan and Uremia

ArticleYear
Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:4

    Topics: Algorithms; Antineoplastic Agents, Phytogenic; Camptothecin; Dose-Response Relationship, Drug; Half-Life; HEK293 Cells; Humans; Irinotecan; Kidney Failure, Chronic; Liver; Liver-Specific Organic Anion Transporter 1; Renal Dialysis; Serum Albumin; Toxins, Biological; Uremia

2017
Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
    Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:6

    Topics: Carboxylesterase; Case-Control Studies; Fatty Acids; Humans; Irinotecan; Kidney Failure, Chronic; Microsomes, Liver; Nitrophenols; Topoisomerase I Inhibitors; Uremia

2018